Progesterone levels and frozen embryo transfer outcomes
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This study looks at how progesterone levels around the time of a frozen embryo transfer might affect the chance of a successful pregnancy. Participants will have their transfer done as usual, and researchers will measure progesterone levels to see if they relate to pregnancy outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 51 years old.
- You are planning a frozen embryo transfer (using embryos that were frozen for later transfer).
- You are using a standard hormone preparation with estrogen and progesterone, including both vaginal progesterone and progesterone injections (like progesterone-in-oil).
- You have at least one embryo that has been tested and found to have the normal number of chromosomes (a 'euploid' embryo) to transfer.
- You meet the usual medical criteria for a frozen embryo transfer at Shady Grove Fertility.
- You are not currently pregnant, breastfeeding, or part of another experimental drug study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of supporting the womb after a frozen embryo transfer: using a standard hormone (progesterone) or a nasal spray (GnRH agonist) that helps the body produce its own progesterone. It aims to see if the nasal spray can improve pregnancy rates.
This study looks at whether the level of progesterone, a hormone that helps prepare the uterus for pregnancy, on the day of embryo transfer affects the chance of a successful pregnancy in women using frozen embryos. It may help doctors understand if adjusting progesterone could improve outcomes.
This study looks at how progesterone levels on the day of embryo transfer affect the chance of pregnancy in frozen embryo transfer (FET) cycles. It aims to find if certain levels can improve outcomes for patients.
This trial compares two ways of timing progesterone support for frozen embryo transfer in women with regular cycles. It aims to find which approach gives the best chance of pregnancy.
This Phase 3 study tests whether adding micronized progesterone during frozen embryo transfer cycles helps support embryo implantation and pregnancy. You may benefit if your care team is already preparing the uterus with hormone therapy for a blastocyst transfer.
This study tests how hormone levels (progesterone) change day to day in the lining of the uterus (endometrium) during an embryo transfer in a medicated cycle. The goal is to better time the transfer and improve success rates.
Hear when a new IVF trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.